VIEWPOINTS_Sheri Lewis1_Dr. Ger Brophy2_2023

Sheri Lewis and Dr. Ger Brophy of Avantor Share Insights on the Opening of a New Distribution Centre

Shots:Sheri talked about the opening of the new distribution center in Dublin, Ireland. The opening of the center highlighted Avantor’s continued investment to expand its global footprint strengthening its ability to provide essential products and services to the marketsDr. Ger Brophy spoke about the key benefits of the center to global biopharma customers.…

BySenior EditorJune 12, 2023

EVENTS

Need Coverage of 41st Annual J.P. Morgan Healthcare Conference 2023?

Need Coverage of 41st Annual J.P. Morgan Healthcare Conference 2023?Shots:The 41st Annual J.P. Morgan Healthcare Conference (JPM 2023) will take place from January 9th to 12th, 2023, in San Francisco, US. It will gather thousands of global investors, emerging companies, innovative technology creators, and members of the investment communityWith hundreds of presentations lined up…

BySenior EditorDecember 30, 2022

VIEWPOINTS

Michael Scheffler, Vice President, Head of Life Science PCR at QIAGEN Shares Insights on the Addition of New Biopharma Products to its Digital PCR Portfolio

Shots:Michael spoke about the addition of new biopharma products through QIAcuity series of digital PCR (dPCR) instruments to its digital PCR portfolioHe also talked about how QIAGEN’s dPCR assays are quicker than systems as it was launched in four different master mixes allowing experiments leading to precise resultsThe interview gives an understanding of…

BySenior EditorOctober 12, 2022

THOUGHTSPOT

Medical Representatives Opinion Survey for Business Continuity with New Normal

K. K. Consulting Services has conducted this survey by contacting around 2200 medical representatives across the India using google forms.Objective of SurveyThe purpose of this survey is to design a platform for pharmaceutical sales professionals (PSP) to share their opinion about business continuity challenges faced by them due to the present COVID pandemic situation. The nature…

BySenior EditorAugust 24, 2020

TOP 20

Top COVID-19 Deals (Part II): Biopharma Vaccine Development

The recent emergence of the coronavirus SARS-CoV-2 and the COVID-19 pandemic has spurred global healthcare and life sciences companies- as well as government agencies- to partner at unprecedented speed to develop vaccines- treatments- and testsThis article covers the last four months of deal data provided by Chris Dokomajilar of DealFormaOur team at PharmaShots…

ByPrince GiriMay 1, 2020

TOP 20

Top COVID-19 Deals (Part I): Biopharma Drug Development

The recent emergence of the coronavirus SARS-CoV-2 and the COVID-19 pandemic has spurred global healthcare and life sciences companies- as well as government agencies- to partner at an unprecedented speed to develop vaccines- treatments- and testsThis article covers last four months of deal data provided by Chris Dokomajilar of DealForma.This first part is…

ByPrince GiriApril 17, 2020

TOP 20

Top Biopharma Deal Terminations of 2018-2019 by Total Value Received

The biopharma industry saw a significant increase in the number of deal terminations in the last two years. Clinical and regulatory results- change in control limitations- and strategic reprioritizations were among the most common reasons for deal termination. We used the DealForma database to track partnership terminations announced in 2018 and 2019. We compiled a list of…

ByPrince GiriJanuary 3, 2020

TOP 20

Top 20 BioPharma Companies based on 2018 Total Revenue

The global pharma companies have been advancing their pipelines with emerging needs of patients. Pharma companies are also focusing on diagnostics & devices- which were emerged as one of major revenue generator in 2018- with the development of new products and devices. The year 2018 also proved to be a record with approval of 55…

ByPrince GiriMay 1, 2019

Sheri Lewis and Dr. Ger Brophy of Avantor Share Insights on the Opening of a New Distribution Centre

Need Coverage of 41st Annual J.P. Morgan Healthcare Conference 2023?

Michael Scheffler, Vice President, Head of Life Science PCR at QIAGEN Shares Insights on the Addition of New Biopharma Products to its Digital PCR Portfolio

Medical Representatives Opinion Survey for Business Continuity with New Normal

Top COVID-19 Deals (Part II): Biopharma Vaccine Development

Top COVID-19 Deals (Part I): Biopharma Drug Development

Top Biopharma Deal Terminations of 2018-2019 by Total Value Received

Top 20 BioPharma Companies based on 2018 Total Revenue

Contact US

OUR INFORMATION

FOLLW US

FOLLW US

Sign Up to Our Newsletter